Soo J. Park, Omid Najmi, Jennifer Chang, Tuyet Tan, Poorva Vaidya, Warren Allen Chow, Adil Daud, Gregory A. Daniels, Silvia Boffo. "A phase 2 study of neoadjuvant nivolumab + relatlimab versus nivolumab in patients with resectable high-risk basal cell carcinoma.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps9613